Saba Capital Management Amends Filing for Invesco PA Muni Trust

TL;DR

Saba Capital updated its 13D on Invesco PA Muni Trust. Watch for potential moves.

AI Summary

Saba Capital Management, L.P. has filed an amendment (No. 6) to its Schedule 13D/A regarding Invesco Pennsylvania Value Municipal Income Trust, as of May 6, 2024. The filing indicates a change in beneficial ownership, though specific new holdings or changes in percentage are not detailed in this excerpt. Saba Capital Management, L.P. is based in New York, NY.

Why It Matters

This filing signals potential shifts in significant ownership stakes within the Invesco Pennsylvania Value Municipal Income Trust, which could influence the trust's management or strategic direction.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings often indicate a change in activist investor strategy or significant stake adjustments, which can introduce volatility.

Key Players & Entities

• Saba Capital Management, L.P. (company) — Filing entity
• Invesco Pennsylvania Value Municipal Income Trust (company) — Subject company
• 20240506 (date) — Filing date

FAQ

Key Financial Figures

• $27,647,978 — ported herein. A total of approximately $27,647,978 was paid to acquire the Common Shares r
• $5,000 — reed to advance an amount not to exceed $5,000 to cover the reimbursement of fees the

Filing Documents

• p24-1665sc13da.htm (SC 13D/A) — 87KB
• 0000902664-24-003309.txt ( ) — 89KB

is hereby amended and supplemented as follows

Item 4 is hereby amended and supplemented as follows: On May 2, 2024, Saba Capital Master Fund, Ltd., a private fund advised by Saba Capital, submitted to the Issuer a notice of intent informing the Issuer of its intention to nominate a slate of three independent trustee candidates – Ketu Desai, Paul Kazarian and Jassen Trenkow (the “ Nominees ”), for election to the Board at the Issuer’s 2024 annual meeting of shareholders (the “ Annual Meeting ”). Item 5. INTEREST IN SECURITIES OF THE ISSUER (a) See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used herein are calculated based upon 23,829,544 shares of common stock outstanding as of 2/29/24, as disclosed in the company’s N-CSR filed 5/2/24 CUSIP No. 46132K109 SCHEDULE 13D Page 6 of 8 Pages (b) See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. (c) The transactions in the Common Shares effected within the past sixty days by the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. (d) The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares. (e) Not applicable. Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER

is hereby amended and supplemented by the addition of the following

Item 6 is hereby amended and supplemented by the addition of the following: Each of the Nominees, except for Paul Kazarian, has entered into a nomination agreement (collectively, the “ Nominee Agreement ”) with Saba Capital substantially in the form attached as Exhibit 2 to this Schedule 13D/A whereby the Nominees agreed to stand for election as individual trustees of the Issuer in connection with a proxy solicitation which may be conducted in respect of the 2024 Annual Meeting and agreed not to acquire or dispose of any securities of the Issuer without prior written approval of Saba Capital and whereby, Saba Capital has agreed to advance an amount not to exceed $5,000 to cover the reimbursement of fees the nominees may incur in connection with their nominations and defend and indemnify the Nominees against, and with respect to, any losses that may be incurred by the Nominees in the event they become a party to litigation based on their nominations as candidates for election to the Board and the solicitation of proxies in support of their election. The foregoing summary of the Nominee Agreement is not complete and is qualified in its entirety by reference to the full text of the form of Nominee Agreement, a copy of which is attached as Exhibit 2 and is incorporated by reference herein. Item 7. MATERIAL TO BE FILED AS EXHIBITS Exhibit 2: Form of Nominee Agreement CUSIP No. 46132K109 SCHEDULE 13D Page 7 of 8 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: May 6, 2024 SABA CAPITAL Management, L.P. By: /s/ Michael D’Angelo Name: Michael D’Angelo Title: Chief Compliance Officer SABA CAPITAL Management GP, LLC By: /s/ Michael D’Angelo Name:Michael D’Angelo Title:Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D’Angelo Name: Michael D’Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: CUSIP No. 46132K109 SCHEDULE 13D Page 8 of 8 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 3/7/2024 Buy 27,652 10.15 3/8/2024 Buy 200 10.19 3/11/2024 Buy 10,373 10.22 3/12/2024 Buy 6,989 10.23 3/19/2024 Buy 11,342 10.21 3/28/2024 Buy 5 10.25 4/12/2024 Buy 13,333 10.01 4/15/2024 Buy 2,973 9.94 4/16/2024 Buy 574,792 9.93 4/16/2024 Sell (574,792) 9.93 4/18/2024 Buy 150,000 9.93 4/18/2024 Sell (150,000) 9.93 5/2/2024 Buy 30,935 9.96 5/3/2024 Buy 2,199 10.1 EXHIBIT 2 Form of Nominee Agreement Saba Capital Management, L.P. 405 Lexington Avenue, 58th Floor New York, NY 10174 [__________], 2024 Private & Confidential [Nominee] [Business Address] Dear [Nominee]: This will confirm our understanding as follows: You agree that you are willing, should we so elect, to become a member of a slate of nominees (the “ Slate ”) of an affiliat

View Full Filing

View this SC 13D/A filing on SEC EDGAR